MHRA seizes £2 million of fake retatrutide and tirzepatide weight-loss pens in Birmingham
- The UK medicines regulator and West Midlands Police seized more than 12,000 fake weight-loss pens in a raid on 14 October 2026.
- The pens were sold as retatrutide and tirzepatide; packaging for around 30,000 more products was also found.
- Retatrutide is not authorised in the UK, and products sold under that name outside clinical trials are illegal.
- The MHRA urges people to obtain GLP-1 medicines only from a registered pharmacy with a valid prescription.
The Medicines and Healthcare products Regulatory Agency (MHRA) and West Midlands Police have seized fake weight-loss medicines worth around £2 million in a raid on an industrial unit in Birmingham. More than 12,000 pens labelled as retatrutide and tirzepatide were recovered on 14 October 2026, along with packaging for around 30,000 more products.
Why these products are dangerous
Tim Duffield, head of intelligence at the MHRA's Criminal Enforcement Unit, described the site as a "filthy warehouse" and said the products had not been assessed for safety, quality or effectiveness, with no guarantee of what they contain or whether they are contaminated.
Retatrutide, an experimental drug that acts on three hormone receptors, has not been authorised in the UK. Anything sold under that name outside legitimate clinical trials is being supplied illegally. Tirzepatide is licensed, but only when prescribed and dispensed through regulated channels.
A series of raids
The MHRA says this is the latest in a run of operations against illegal GLP-1 medicines. In May 2026 two people were arrested after around 12,000 doses were recovered from a country estate; in February 2026 about 2,000 doses awaiting dispatch were seized; and in October 2025 the agency dismantled the first illicit weight-loss medicine production facility found in the UK.
Advice for the public
The regulator advises anyone considering GLP-1 treatment to speak to a healthcare professional and to obtain medicines only from a registered pharmacy against a valid prescription. Suspected side effects can be reported through the Yellow Card scheme.
Source: MHRA (GOV.UK)
This story is relayed from the source named above; responsibility for its content rests with the original source.
FAQ
What did the MHRA seize in Birmingham?
The MHRA and West Midlands Police seized more than 12,000 fake retatrutide and tirzepatide weight-loss pens, worth about £2 million, plus packaging for around 30,000 more products.
Is retatrutide approved in the UK?
No. Retatrutide is not authorised in the UK, and products sold as retatrutide outside legitimate clinical trials are supplied illegally.
Why are fake weight-loss pens dangerous?
Fake weight-loss pens have not been tested for safety, quality or effectiveness, so their contents are unknown and they may be contaminated with harmful substances.
How can people buy weight-loss medicines safely in the UK?
The MHRA advises obtaining weight-loss medicines only from a registered pharmacy with a valid prescription after speaking to a healthcare professional.
How can side effects from weight-loss medicines be reported in the UK?
Suspected side effects from medicines in the UK can be reported to the MHRA through the Yellow Card scheme website or app.



